CMS Launches Program to Expand Medicare Access to Anti-Obesity Drugs

The Centers for Medicare & Medicaid Services (CMS) has initiated the 'Bridge model,' a new program designed to provide eligible Medicare beneficiaries with access to anti-obesity medications. This initiative, which commenced on July 1, 2026, aims to enhance treatment options for seniors, foster improved health outcomes, and potentially reduce overall healthcare costs. It represents a significant policy change for Medicare coverage.